SGLT2i improves outcomes in HFpEF and HFmrEF3' education - Aug. 27, 2022 - Prof. Scott Solomon, MD - Boston, MA, USA
This video was recorded during the ESC Congress 2022 in Barcelona, Spain.
Scott D. Solomon, MD is the Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School and directs the Clinical Trials Outcomes Center at Brigham and Women’s Hospital.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.